Cencora Stock Tumbles as Revenue Warning Overshadows Higher Profit Forecast
Cencora cut its full-year revenue growth forecast after missing quarterly revenue estimates, sending shares down 13.5% to $264.49. U.S. Healthcare Solutions revenue rose 2.9% to $68.8 billion, below analyst expectations. Total revenue reached $78.4 billion, missing Wall Street’s $81.09 billion estimate. The company raised its adjusted earnings forecast and plans $1 billion in share buybacks by end of 2026.